Here are five things to know:
1. The company issued 504,538 common shares at $1.35 per share.
2. The aggregate gross proceeds are CDN $681,126.
3. Proceeds from the offering will be used for general working capital purposes.
4. Director James Snow directly or indirectly subscribed for 84,444 common shares under the offering; Director David Rosenkrantz subscribed to 112,000.
5. The common shares issued under the offering are subject to a four-month hold period expiring May 10, 2015.
More articles on orthopedic devices:
8 trends in the biocompatible materials market
K2M revenue up 18% in 2014—5 things to know
Could Congress repeal the medical device tax without Obama? 5 things to know
